person · Reporting owner

Bushman Julie L

Disclosed activity across 5 companies

Tapewire entity: 61243
SEC CIK: 0001518599

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
3M COMMM · Entity 1275	Executive Vice President	February 04, 2020	February 21, 2020
Adient plcADNT · Entity 4713	Director	March 10, 2026	March 12, 2026
BIO-TECHNE CorpTECH · Entity 3479	Director	October 30, 2025	November 03, 2025
Phillips 66PSX · Entity 2915	Director	January 15, 2026	January 20, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

3M CO

Report date February 04, 2020 · Filed February 21, 2020 · Amendment

Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	38,034.1214	Reported balance After 2020-02-04 transaction · row 1 Amendment: may correct only part of an earlier disclosure. 1 source row Row 1 · 2020-02-04 · Tax withholding · Disposed 1,957 · Balance 38,034.1214 F1: The number of shares previously reported as being withheld for the payment of taxes was estimated. This amendment is being filed to update the Form 4 with the actual number of shares withheld.

Filing footnotes · ownership attribution and instrument terms

F1: The number of shares previously reported as being withheld for the payment of taxes was estimated. This amendment is being filed to update the Form 4 with the actual number of shares withheld.

Adient plc

Report date March 10, 2026 · Filed March 12, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	Direct	59,666	Reported balance After 2026-03-10 transaction · row 1 1 source row Row 1 · 2026-03-10 · Grant · Acquired 8,208 · Balance 59,666 F1: Shares delivered as compensation for service as a director under the Adient plc 2021 Omnibus Incentive Plan.

Filing footnotes · ownership attribution and instrument terms

F1: Shares delivered as compensation for service as a director under the Adient plc 2021 Omnibus Incentive Plan.

BIO-TECHNE Corp

Report date October 30, 2025 · Filed November 03, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	8,775	Reported balance After 2025-10-30 transaction · row 1 1 source row Row 1 · 2025-10-30 · Grant · Acquired 1,640 · Balance 8,775
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.96 · Expires 2035-10-30	Direct	3,777	Reported balance After 2025-10-30 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2025-10-30 · Grant · Acquired 3,777 · Balance 3,777 F1: The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $69.72 · Expires 2030-07-31	Direct	1,444	Reported balance Holding disclosure · report date 2025-10-30 · row 2 Instrument identity requires review; Table II rows are not merged. 1 source row Row 2 · Balance 1,444
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $63.92 · Expires 2030-10-29	Direct	6,028	Reported balance Holding disclosure · report date 2025-10-30 · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · Balance 6,028
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.81 · Expires 2031-10-28	Direct	2,532	Reported balance Holding disclosure · report date 2025-10-30 · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · Balance 2,532
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $73.94 · Expires 2032-10-27	Direct	3,460	Reported balance Holding disclosure · report date 2025-10-30 · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · Balance 3,460
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.51 · Expires 2033-10-26	Direct	3,937	Reported balance Holding disclosure · report date 2025-10-30 · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · Balance 3,937
Stock Options (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $68.37 · Expires 2034-10-24	Direct	3,511	Reported balance Holding disclosure · report date 2025-10-30 · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · Balance 3,511

Filing footnotes · ownership attribution and instrument terms

F1: The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders.

Phillips 66

Report date January 15, 2026 · Filed January 20, 2026

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	14,841.0142	Reported balance After 2026-01-15 transaction · row 1 Account or security details depend on footnotes; rows are not merged. 1 source row Row 1 · 2026-01-15 · Grant · Acquired 1,423 · Balance 14,841.0142 F1: Annual grant to non-employee directors of Restricted Stock Units (RSUs) that convert to Phillips 66 common stock on a 1-for-1 basis. F2: The price reflected above is the average of the high and the low price of Phillips 66's stock on January 15, 2026. F3: All shares are RSUs, including shares acquired through routine dividend transactions that are exempt under Rule 16a-11.

Filing footnotes · ownership attribution and instrument terms

F1: Annual grant to non-employee directors of Restricted Stock Units (RSUs) that convert to Phillips 66 common stock on a 1-for-1 basis.

F2: The price reflected above is the average of the high and the low price of Phillips 66's stock on January 15, 2026.

F3: All shares are RSUs, including shares acquired through routine dividend transactions that are exempt under Rule 16a-11.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

JOHNSON CONTROLS INC

Report date September 02, 2016 · Filed September 07, 2016

Section 16 reporting ended · disclosed 2016-09-07. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Common StockSEC Table I · non-derivative	Direct	0	Reported balance After 2016-09-02 transaction · row 1 1 source row Row 1 · 2016-09-02 · Disposition to issuer · Disposed 13,909 · Balance 0 F1: Each share of Johnson Controls, Inc. ("Johnson Controls") was converted into 0.8357 ordinary shares of Johnson Controls International plc (formerly Tyco International plc) ("JCI plc") and $5.7293 in cash in connection with the closing of the merger between Johnson Controls and JCI plc (the "merger").

Filing footnotes · ownership attribution and instrument terms

F1: Each share of Johnson Controls, Inc. ("Johnson Controls") was converted into 0.8357 ordinary shares of Johnson Controls International plc (formerly Tyco International plc) ("JCI plc") and $5.7293 in cash in connection with the closing of the merger between Johnson Controls and JCI plc (the "merger").

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
March 10, 2026 Filed Mar 12, 2026 20:16 UTC	Adient plc ADNT · Entity 4713	GrantOrdinary Shares	8,208	Not disclosed	Not disclosed	Disclosure SEC source: 0001670541-26-000047 · wk-form4_1773346596.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,666 F1 · price: Shares delivered as compensation for service as a director under the Adient plc 2021 Omnibus Incentive Plan. Read SEC document
January 15, 2026 Filed Jan 20, 2026 17:10 UTC	Phillips 66 PSX · Entity 2915	GrantCommon Stock	1,423	$140.56	$200,016.88	Disclosure SEC source: 0001518599-26-000002 · wk-form4_1768947014.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,841.0142 F1 · shares: Annual grant to non-employee directors of Restricted Stock Units (RSUs) that convert to Phillips 66 common stock on a 1-for-1 basis. F2 · price: The price reflected above is the average of the high and the low price of Phillips 66's stock on January 15, 2026. F3 · balance_after: All shares are RSUs, including shares acquired through routine dividend transactions that are exempt under Rule 16a-11. Read SEC document
October 30, 2025 Filed Nov 3, 2025 22:38 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantStock Options (Right to Buy) · Derivative	3,777	$0.00 Strike: $60.96	$0.00	Disclosure SEC source: 0000914190-25-000025 · form4.xml · derivative · entry 8 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,777 Underlying: Common Stock · 3,777 shares Expires 2035-10-30 F1 · derivative.exercise_date: The option vests on the earlier of the one year anniversary of the grant date (10/30/2025) or the date of Bio-Techne's 2026 annual meeting of shareholders. Read SEC document
October 30, 2025 Filed Nov 3, 2025 22:38 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantCommon Stock	1,640	$0.00	$0.00	Disclosure SEC source: 0000914190-25-000025 · form4.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,775 Read SEC document
March 11, 2025 Filed Mar 13, 2025 20:17 UTC	Adient plc ADNT · Entity 4713	GrantOrdinary Shares	10,118	Not disclosed	Not disclosed	Disclosure SEC source: 0001670541-25-000046 · wk-form4_1741897053.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,458 F1 · price: Shares delivered as compensation for service as a director under the Adient plc 2021 Omnibus Incentive Plan. Read SEC document
January 15, 2025 Filed Jan 17, 2025 17:55 UTC	Phillips 66 PSX · Entity 2915	GrantCommon Stock	1,684	$118.78	$200,020.30	Disclosure SEC source: 0001534701-25-000023 · wk-form4_1737154532.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,921.3879 F1 · shares: Annual grant to non-employee directors of Restricted Stock Units (RSUs) that convert to Phillips 66 common stock on a 1-for-1 basis. F2 · price: The price reflected above is the average of the high and the low price of the Company's stock on January 15, 2025. F3 · balance_after: All shares are RSUs, including shares acquired through routine dividend transactions that are exempt under Rule 16a-11. Read SEC document
October 24, 2024 Filed Oct 28, 2024 20:42 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantStock Options (Right to Buy) · Derivative	3,511	$0.00 Strike: $68.37	$0.00	Disclosure SEC source: 0001062993-24-018032 · form4.xml · derivative · entry 7 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,511 Underlying: Common Stock · 3,511 shares Expires 2034-10-24 F1 · derivative.exercise_date: The option vests on the earlier of the one year anniversary of the grant date (10/24/2024) or the date of Bio-Techne's 2025 annual meeting of shareholders. Read SEC document
October 24, 2024 Filed Oct 28, 2024 20:42 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantCommon Stock	1,462	$0.00	$0.00	Disclosure SEC source: 0001062993-24-018032 · form4.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,135 Read SEC document
March 12, 2024 Filed Mar 14, 2024 20:20 UTC	Adient plc ADNT · Entity 4713	GrantOrdinary Shares	4,207	Not disclosed	Not disclosed	Disclosure SEC source: 0001670541-24-000056 · wk-form4_1710447589.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,340 F1 · price: Shares delivered as compensation for service as a director under the Adient plc 2021 Omnibus Incentive Plan. Read SEC document
January 16, 2024 Filed Jan 18, 2024 20:08 UTC	Phillips 66 PSX · Entity 2915	GrantCommon Stock	1,524	$131.31	$200,116.44	Disclosure SEC source: 0001534701-24-000021 · wk-form4_1705626498.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,879.3041 F1 · shares: Annual grant to non-employee directors of Restricted Stock Units (RSUs) that convert to Phillips 66 common stock on a 1-for-1 basis. F2 · price: The price reflected above is the average of the high and the low price of the Company's stock on January 16, 2024. F3 · balance_after: All shares are RSUs, including shares acquired through routine dividend transactions that are exempt under Rule 16a-11. Read SEC document
October 26, 2023 Filed Oct 30, 2023 20:52 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantStock Options (Right to Buy) · Derivative	3,937	$0.00 Strike: $61.51	$0.00	Disclosure SEC source: 0001062993-23-019856 · form4.xml · derivative · entry 6 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,937 Underlying: Common Stock · 3,937 shares Expires 2033-10-26 F1 · derivative.exercise_date: The option vests on the earlier of the one year anniversary of the grant date (10/26/2023) or the date of Bio-Techne's 2024 annual meeting of shareholders. Read SEC document
October 26, 2023 Filed Oct 30, 2023 20:52 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantCommon Stock	1,625	$0.00	$0.00	Disclosure SEC source: 0001062993-23-019856 · form4.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,673 Read SEC document
March 07, 2023 Filed Mar 8, 2023 21:28 UTC	Adient plc ADNT · Entity 4713	GrantOrdinary Shares	3,312	Not disclosed	Not disclosed	Disclosure SEC source: 0001670541-23-000068 · wf-form4_167831087132334.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,133 F1 · price: Shares delivered as compensation for service as a director under the Adient plc 2021 Omnibus Incentive Plan. Read SEC document
January 17, 2023 Filed Jan 19, 2023 18:24 UTC	Phillips 66 PSX · Entity 2915	GrantCommon Stock	1,929	$103.69	$200,008.37	Disclosure SEC source: 0001534701-23-000026 · wf-form4_167417064279544.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,004.8119 F1 · shares: Annual grant to non-employee directors of Restricted Stock Units (RSUs) that convert to Phillips 66 common stock on a 1-for-1 basis. The restrictions on the RSUs lapse after the retirement, disability or death of the non-employee director. F2 · price: The price reflected above is the average of the high and the low price of the Company's stock on January 17, 2023. F3 · balance_after: All 9,004.8119 shares are RSUs, including shares acquired through routine dividend transactions that are exempt under Rule 16a-1. Read SEC document
October 27, 2022 Filed Oct 31, 2022 21:19 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantStock Options (Right to Buy) · Derivative	865	$0.00 Strike: $295.77	$0.00	Disclosure SEC source: 0001415889-22-010913 · form4-10312022_021052.xml · derivative · entry 2 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 865 Underlying: Common Stock · 865 shares Expires 2032-10-27 F1 · derivative.exercise_date: The option vests on the earlier of the one year anniversary of the grant date (10/27/2022) or the date of Bio-Techne's 2023 annual meeting of shareholders. Read SEC document
October 27, 2022 Filed Oct 31, 2022 21:19 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantCommon Stock	338	$0.00	$0.00	Disclosure SEC source: 0001415889-22-010913 · form4-10312022_021052.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,012 Read SEC document
March 08, 2022 Filed Mar 10, 2022 21:10 UTC	Adient plc ADNT · Entity 4713	GrantOrdinary Shares	4,531	Not disclosed	Not disclosed	Disclosure SEC source: 0001670541-22-000024 · wf-form4_164694658114706.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,821 F1 · price: Shares delivered as compensation for service as a director under the Adient plc 2021 Omnibus Incentive Plan. Read SEC document
January 14, 2022 Filed Jan 19, 2022 17:13 UTC	Phillips 66 PSX · Entity 2915	GrantCommon Stock	2,284	$87.57	$200,009.88	Disclosure SEC source: 0001534701-22-000018 · wf-form4_164263035316526.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,795.4263 F1 · shares: Annual grant to non-employee directors of Restricted Stock Units (RSUs) that convert to Phillips 66 common stock on a 1-for-1 basis. The restrictions on the RSUs lapse after the retirement, disability or death of the non-employee director. F2 · price: The price reflected above is the average of the high and the low price of the Company's stock on January 14, 2022. F3 · balance_after: All 6,795.4263 shares are RSUs, including shares acquired through routine dividend transactions that are exempt under Rule 16a-1. Read SEC document
October 28, 2021 Filed Nov 1, 2021 20:37 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantStock Option (right to buy) · Derivative	633	$0.00 Strike: $515.24	$0.00	Disclosure SEC source: 0000914190-21-000393 · edgar.xml · derivative · entry 4 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 633 Underlying: Common Stock · 633 shares Expires 2031-10-28 F1 · derivative.exercise_date: The option vests on the earlier of the one year anniversary of the grant date (10/28/2021) or the date of Bio-Techne's 2022 annual meeting of shareholders. Read SEC document
October 28, 2021 Filed Nov 1, 2021 20:37 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantCommon Stock	194	$0.00	$0.00	Disclosure SEC source: 0000914190-21-000393 · edgar.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 674 Read SEC document
March 09, 2021 Filed Mar 10, 2021 21:46 UTC	Adient plc ADNT · Entity 4713	GrantOrdinary Shares	3,553	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-21-010105 · form4.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,290 F1 · price: Shares delivered as compensation for service as a director under the Adient plc 2021 Omnibus Incentive Plan. Read SEC document
January 15, 2021 Filed Jan 20, 2021 17:38 UTC	Phillips 66 PSX · Entity 2915	GrantCommon Stock	2,771	$72.19	$200,045.42	Disclosure SEC source: 0001534701-21-000019 · wf-form4_161118231755012.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,305.562 F1 · shares: Annual grant to non-employee directors of Restricted Stock Units (RSUs) that convert to Phillips 66 common stock on a 1-for-1 basis. The restrictions on the RSUs lapse after the retirement, disability or death of the non-employee director. F2 · price: The price reflected above is the average of the high and the low price of the Company's stock on January 15, 2021. F3 · balance_after: All 4,305.562 are RSUs, including additional units acquired through routine dividend transactions that are exempt under Rule 16a-11. Read SEC document
October 29, 2020 Filed Nov 2, 2020 20:13 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantStock Option (Right to Buy) · Derivative	1,507	$0.00 Strike: $255.69	$0.00	Disclosure SEC source: 0001562180-20-006488 · primarydocument.xml · derivative · entry 2 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,507 Underlying: Common Stock · 1,507 shares Expires 2030-10-29 F1 · derivative.exercise_date: The option vests on the earlier of the one year anniversary of the grant date (10/29/2020) or the date of Bio-Techne's 2021 annual meeting of shareholders. Read SEC document
October 29, 2020 Filed Nov 2, 2020 20:13 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantCommon Stock	391	$0.00	$0.00	Disclosure SEC source: 0001562180-20-006488 · primarydocument.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 480 Read SEC document
August 03, 2020 Filed Aug 5, 2020 21:19 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantStock Option (Right to Buy) · Derivative	361	$0.00 Strike: $278.87	$0.00	Disclosure SEC source: 0001562180-20-005331 · primarydocument.xml · derivative · entry 2 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 361 Underlying: Common Stock · 361 shares Expires 2030-07-31 Read SEC document
August 03, 2020 Filed Aug 5, 2020 21:19 UTC	BIO-TECHNE Corp TECH · Entity 3479	GrantCommon Stock	89	$0.00	$0.00	Disclosure SEC source: 0001562180-20-005331 · primarydocument.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 89 Read SEC document
July 08, 2020 Filed Jul 10, 2020 17:54 UTC	Phillips 66 PSX · Entity 2915	GrantCommon Stock	1,490	$64.60	$96,255.49	Disclosure SEC source: 0001534701-20-000111 · wf-form4_159441805094434.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,490 F1 · shares: Grant of Restricted Stock Units (RSUs) that convert to Phillips 66 common stock on a 1-for-1 basis. The restrictions on the RSUs lapse after the retirement, disability or death of the non-employee director. This is a prorated amount of the annual grant to reflect the new director joining the board. F2 · price: The price reflected above is the average of the high and the low price of the Company's stock on July 8, 2020. Read SEC document
March 12, 2020 Filed Mar 13, 2020 22:33 UTC	Adient plc ADNT · Entity 4713	GrantOrdinary Shares	10,951	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-20-010669 · form4.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,737 F1 · price: Shares delivered as compensation for service as a director under the Adient plc Amended and Restated Director Share Plan. Read SEC document
February 04, 2020 Filed Feb 6, 2020 22:13 UTC	3M CO MMM · Entity 1275	GrantNon-qualified Stock Option (Right to Buy) · Derivative	55,466	$0.00 Strike: $157.24	$0.00	Disclosure SEC source: 0001127602-20-004028 · form4.xml · derivative · entry 4 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,466 Underlying: Common Stock · 55,466 shares Expires 2030-02-03 F4 · derivative.exercise_date: The stock option will vest and become exercisable in a series of three equal installments on each of the first, second and third anniversary of the grant date. Read SEC document
February 04, 2020 Filed Feb 6, 2020 22:13 UTC	3M CO MMM · Entity 1275	Tax withholdingCommon Stock	1,956.763	$0.00	$0.00	Disclosure SEC source: 0001127602-20-004028 · form4.xml · nonDerivative · entry 2 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,034.3584 F3 · shares: The number of shares withheld for taxes was estimated and will be revised by amendment, if necessary. Read SEC document
February 04, 2020 Filed Feb 6, 2020 22:13 UTC	3M CO MMM · Entity 1275	GrantCommon Stock	6,326.204	$0.00	$0.00	Disclosure SEC source: 0001127602-20-004028 · form4.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,991.1214 F1 · shares: Represents shares of 3M common stock that will be delivered pursuant to the terms of a performance share award made to the reporting person on March 1, 2017. The performance-based vesting requirements applicable to such award were satisfied on the date reported in Column 2 above, which represents the date on which the level of performance attained was certified. F2 · balance_after: Includes shares acquired under 3M's General Employee Stock Purchase Plan. Read SEC document
February 04, 2020 Filed Feb 21, 2020 19:02 UTC Amendment	3M CO MMM · Entity 1275	Tax withholdingCommon Stock	1,957	$0.00	$0.00	Disclosure SEC source: 0001127602-20-006862 · form4a.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,034.1214 F1 · shares: The number of shares previously reported as being withheld for the payment of taxes was estimated. This amendment is being filed to update the Form 4 with the actual number of shares withheld. Read SEC document
December 02, 2019 Filed Dec 3, 2019 19:50 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	6,879	$170.16	$1,170,530.64	Disclosure SEC source: 0001127602-19-034087 · form4.xml · nonDerivative · entry 3 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,651.733 F1 · shares: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2019. Read SEC document
November 29, 2019 Filed Dec 3, 2019 19:50 UTC	3M CO MMM · Entity 1275	Exercise / conversionRestricted Stock Units · Derivative	12,646	$0.00	$0.00	Disclosure SEC source: 0001127602-19-034087 · form4.xml · derivative · entry 5 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 12,646 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represented a contingent right to receive one share of 3M common stock, and converted into common stock on the vesting day. F3 · derivative.exercise_date: The restricted stock units vest 100% five years from the grant date of December 1, 2014. F3 · derivative.expiration_date: The restricted stock units vest 100% five years from the grant date of December 1, 2014. Read SEC document
November 29, 2019 Filed Dec 3, 2019 19:50 UTC	3M CO MMM · Entity 1275	Tax withholdingCommon Stock	5,767	$169.77	$979,063.59	Disclosure SEC source: 0001127602-19-034087 · form4.xml · nonDerivative · entry 2 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,530.733 Read SEC document
November 29, 2019 Filed Dec 3, 2019 19:50 UTC	3M CO MMM · Entity 1275	Exercise / conversionCommon Stock	12,646	$169.77	$2,146,911.42	Disclosure SEC source: 0001127602-19-034087 · form4.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,297.733 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
March 11, 2019 Filed Mar 12, 2019 21:36 UTC	Adient plc ADNT · Entity 4713	GrantOrdinary Shares	9,558	Not disclosed	Not disclosed	Disclosure SEC source: 0001127602-19-011080 · form4.xml · nonDerivative · entry 1 Bushman Julie L · CIK 0001518599 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,786 F1 · price: Shares delivered as compensation for service as a director under the Adient plc 2016 Director Share Plan. Read SEC document
February 07, 2019 Filed Feb 11, 2019 14:15 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	328	$199.83	$65,544.24	Disclosure SEC source: 0001127602-19-004983 · form4.xml · nonDerivative · entry 27 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,652.0024 Read SEC document
February 07, 2019 Filed Feb 11, 2019 14:15 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	201	$199.82	$40,163.82	Disclosure SEC source: 0001127602-19-004983 · form4.xml · nonDerivative · entry 26 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,980.0024 Read SEC document
February 07, 2019 Filed Feb 11, 2019 14:15 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	110	$199.81	$21,979.10	Disclosure SEC source: 0001127602-19-004983 · form4.xml · nonDerivative · entry 25 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,181.0024 Read SEC document
February 07, 2019 Filed Feb 11, 2019 14:15 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	400	$199.81	$79,922.00	Disclosure SEC source: 0001127602-19-004983 · form4.xml · nonDerivative · entry 24 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,291.0024 Read SEC document
February 07, 2019 Filed Feb 11, 2019 14:15 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	1	$199.80	$199.80	Disclosure SEC source: 0001127602-19-004983 · form4.xml · nonDerivative · entry 23 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,691.0024 Read SEC document
February 07, 2019 Filed Feb 11, 2019 14:15 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	389	$199.79	$77,718.31	Disclosure SEC source: 0001127602-19-004983 · form4.xml · nonDerivative · entry 22 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,692.0024 Read SEC document
February 07, 2019 Filed Feb 11, 2019 14:15 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	20	$199.78	$3,995.60	Disclosure SEC source: 0001127602-19-004983 · form4.xml · nonDerivative · entry 21 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,081.0024 Read SEC document
February 07, 2019 Filed Feb 11, 2019 14:15 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	100	$199.78	$19,977.50	Disclosure SEC source: 0001127602-19-004983 · form4.xml · nonDerivative · entry 20 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,101.0024 Read SEC document
February 07, 2019 Filed Feb 11, 2019 14:15 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	380	$199.77	$75,912.60	Disclosure SEC source: 0001127602-19-004983 · form4.xml · nonDerivative · entry 19 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,201.0024 Read SEC document
February 07, 2019 Filed Feb 11, 2019 14:15 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	100	$199.72	$19,972.00	Disclosure SEC source: 0001127602-19-004983 · form4.xml · nonDerivative · entry 18 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,581.0024 Read SEC document
February 07, 2019 Filed Feb 11, 2019 14:15 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	100	$199.69	$19,969.00	Disclosure SEC source: 0001127602-19-004983 · form4.xml · nonDerivative · entry 17 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,681.0024 Read SEC document
February 07, 2019 Filed Feb 11, 2019 14:15 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	200	$199.67	$39,934.00	Disclosure SEC source: 0001127602-19-004983 · form4.xml · nonDerivative · entry 16 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,781.0024 Read SEC document
February 07, 2019 Filed Feb 11, 2019 14:15 UTC	3M CO MMM · Entity 1275	SaleCommon Stock	500	$199.65	$99,822.50	Disclosure SEC source: 0001127602-19-004983 · form4.xml · nonDerivative · entry 15 Bushman Julie L · CIK 0001518599 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,981.0024 Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.